Navigation Links
Amgen Award For Science Teaching Excellence Honors Outstanding Teachers
Date:6/19/2013

THOUSAND OAKS, Calif., June 19, 2013 /PRNewswire/ -- Amgen is pleased to announce the nine science teachers in the United States, Canada and Puerto Rico who are this year's recipients of the Amgen Award for Science Teaching Excellence (AASTE). Now in its 21st year, the award recognizes extraordinary teachers at the kindergarten through 12th grade level who have an outstanding ability to inspire students and produce results in science education.

With a long-standing commitment to science education, Amgen established the teacher awards program to promote and encourage science teaching excellence in public and private schools. Since the program's inception in 1992, Amgen has awarded more than $3 million in cash awards and grants to educators in communities where Amgen operates who have made exceptional science-teaching contributions.

"At Amgen, we are keenly aware of the importance of inspiring and preparing the next generation of scientists," said Joseph P. Miletich, M.D., Ph.D., senior vice president of Research and Development at Amgen. "We applaud each of the award recipients for their dedication to delivering quality science education to tomorrow's innovators."

In 2013, the Award for Science Teaching Excellence winners were honored at surprise presentations at their schools. The 2013 award recipients are:

Mary Murphy, The Urban School of San Francisco, San Francisco, Calif.
Laura Todis, Sierra High School, Fillmore, Calif.
Mark Paricio, Smoky Hill High School, Aurora, Colo.
Susan Buehner, Brandeis Elementary School, Louisville, Ky.
Rebekah Ravgiala, Tyngsborough High School, Tyngsborough, Mass.
Luz Burgos, Colegio Radians, Cayey, Puerto Rico
David Upegui, Central Falls High School, Central Falls, R.I.
Amanda Rainwater, Bothell High School, Bothell, Wash.
Glyn Davies, Henry Anderson Elementary School, Richmond, British Columbia, Canada

Winners are selected based on a variety of criteria including, among others, a teacher's ability to effectively engage students while deepening their scientific understanding, the plan for the use of grant money to improve science education resources in their schools, and a letter of recommendation.

The nine selected winners receive the following benefits:

  • An unrestricted cash award of $5,000 USD or $5,000 CAD; and
  • A restricted $5,000 USD or $5,000 CAD cash grant to the recipient's school for the expansion or enhancement of a school science program, science resources, or the professional development of the school's science teachers.

Amgen partnered with Education Development Center (EDC) to select the 2013 AASTE recipients. EDC is a global non-profit organization that designs, delivers and evaluates innovative programs to address some of the world's most urgent challenges in education, health, and economic opportunity.

The AASTE awards provided to teachers in the United States were funded by the Amgen Foundation and the award in Canada was funded by Amgen.

For more information about this year's winners and the program, please visit http://www.amgen.com/citizenship/aaste.html.

About the Amgen Foundation
The Amgen Foundation (www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. To date, the Foundation has donated over $200 million in grants to nonprofit organizations throughout the United States, Puerto Rico and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally. The Amgen Foundation can be followed on Twitter at www.twitter.com/AmgenFoundation.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping people around the world in the fight against serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Kristen Davis, 805-447-3008 (media)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
2. Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma
3. Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
4. Amgen And Astellas Announce Japan Alliance
5. Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference
6. Amgen To Present At The UBS Global Life Sciences Conference
7. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
8. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
9. Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States
10. Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
11. Amgens First Quarter 2013 Revenues Increased 5 Percent To $4.2 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $1.96
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... PHOENIX , March 28, 2017  Today, ... Pharmacy released a new white paper to ... use of latex in healthcare. Specifically, there is substantial confusion ... fact, the FDA has urged manufacturers to drop the term ... labels, because of the challenge to ensure a product is ...
(Date:3/28/2017)... ALBANY, New York , March 28, 2017 /PRNewswire/ ... features a largely consolidated vendor landscape, with the top ... and Agilent Technologies accounting for a significant 49% of ... in a recent report. The vendor landscape is intensely ... large share in the overall market. These factors have ...
(Date:3/28/2017)...  Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: ... directors: Christopher Gabrieli , ... as chairman of the board of Akcea Therapeutics. ... Forest Laboratories. Sandford D. Smith , ... "We are excited to announce this expansion to our ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... ... HealthCareMandA.com will host an important webinar — Home Health & Hospice: Buying, ... of the webinar will also be made available following its live presentation. The webinar ... still popular targets for healthcare investors. This highly fragmented sector bounced back in 2016, ...
(Date:3/29/2017)... (PRWEB) , ... March 29, ... ... suburbs and South Hills of Pittsburgh now have easier access to the ... only by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and ...
(Date:3/29/2017)... ... ... has helped over 1.5 million SharePoint users learn the content management system faster and ... for SharePoint was at the farm level. Enterprises using SharePoint Online in Office 365 ... recently released a modified version of the Help System, VisualSP for Site Collections, which ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati ... to directly address the resolution to globally reduce the harmful use of alcohol ... of FDA and TTB approved ingredients that when infused into alcohol, renders the ...
(Date:3/28/2017)... ... ... The Thyroid Secret is a specialized 9-part documentary series ... recently launched on March 1, and Dr. Wentz discussed varied benefits and aspects ... Wentz is a licensed pharmacist and a foremost thyroid specialist. After being diagnosed ...
Breaking Medicine News(10 mins):